Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT

Clinical Nuclear Medicine

Volumn 36, Issue 9, 2011, Pages 800-802

  Amzat, Rianot ^a   Taleghani, Pooneh ^a   Savir Baruch, Bital ^a   Nieh, Peter T ^b   Master, Viraj A ^b   Halkar, Raghuveer K ^a   Lewis, Melinda M ^c   Faurot, Michelle ^b   Bellamy, Leah M ^a   Goodman, Mark M ^a   Schuster, David M ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b Departments of Urology   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti 3 F 18 FACBC; PET; prostate cancer

Indexed keywords

ANTI 1 AMINO 3 18 F FLUOROCYCLOBUTYL 1 CARBOXYLIC ACID; TRACER; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ARTICLE; ASCITES; BONE LESION; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY;

AGED; CARBOXYLIC ACIDS; CYCLOBUTANES; HUMANS; MALE; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS;

EID: 80051763998     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318219b47e     Document Type: Article

References (9)

1. Schuster DM, Votaw JR, Nieh PT, et al. Initial experience with the anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J Nucl Med. 2007;48:56-63. (Pubitemid 47555376)
2. Schuster DM, Savir-Baruch B, Nieh PT, et al. Report of a clinical trial of anti-1 amino 3 [18F]fluorocyclobutane-1-carboxylic acid (anti-[18F] FACBC) PET-CT in recurrent prostate carcinoma. J Nucl Med. 2010;51(suppl 2):127P.
3. Saif MW. Malignant ascites associated with carcinoma of the prostate. J App Res. 2005;5:305.
4. Kehinde EO, Abdeen SM, Al-Hunayan A, et al. Prostate cancer metastatic to the omentum. Scand J Urol Nephrol. 2002;36:225.
5. Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655.
6. Agheli A, Patsiornik Y, Chen Y, et al. Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip. Radiol Case Rep. 2009;4:288.
7. Jani AB, Fox TH, Whitaker D, et al. Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (Anti-[F-18] FACBC) to guide Prostate Cancer Radiotherapy Target Design. Clin Nucl Med. 2009;34:279-284.
8. Oka S, Hattori R, Kurosaki F, et al. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. J Nucl Med. 2007;48:46-55. (Pubitemid 47555375)
9. Nye JA, Schuster DM, Yu W, et al. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-F-18 FACBC in humans. J Nucl Med. 2007;48:1017-1020. (Pubitemid 46909932)